Ticker,Name,Market Cap,Sector,Business Summary,Industry,Shares Outstanding,Institution Ownership,Current Price,52-Week High,52-Week Low,Enterprise Value,Beta,Weekly Price Change %,Monthly Price Change %,Quarterly Price Change %,Half-Yearly Price Change %,Yearly Price Change %,YTD Price Change %,2019 Revenues,2020 Revenues,2021 Revenues,2022 Revenues,2023 Revenues,2024 Revenues,2025 Revenues,2019 Net Income,2020 Net Income,2021 Net Income,2022 Net Income,2023 Net Income,2024 Net Income,2025 Net Income,2019 EBITDA,2020 EBITDA,2021 EBITDA,2022 EBITDA,2023 EBITDA,2024 EBITDA,2025 EBITDA,2019 EBIT,2020 EBIT,2021 EBIT,2022 EBIT,2023 EBIT,2024 EBIT,2025 EBIT,Currency,Unit
ASMB,"Assembly Biosciences, Inc.",73907464.0,Healthcare,"Assembly Biosciences, Inc., a biotechnology company, develops therapeutic candidates for the treatment of viral diseases in the United States. It develops ABI-5366 and ABI-1179, which is in Phase 1a/1b clinical trial targeting recurrent genital herpes; and ABI-6250, an oral hepatitis delta virus entry inhibitor that is in Phase 1a clinical studies. The company also offers ABI-4334, a next-generation capsid assembly modulator which is in Phase 1b clinical trials, for the treatment of hepatitis B virus. In addition, it provides an oral non-nucleoside polymerase inhibitor indicated for transplant-associated herpesviruses; and small molecule interferon-a receptor to treat hepatitis B and delta virus. Further, Assembly Biosciences, Inc. has collaboration agreement with BeiGene, Ltd. to develop and commercialize the novel core inhibitor product candidates for chronic HBV infection in the People's Republic of China, Hong Kong, Taiwan, and Macau; and clinical trial collaboration agreement with Arbutus Biopharma Corporation to conduct a randomized, multi-center, and open-label clinical trials, as well as agreement with Antios Therapeutics, Inc. for triple combination therapy. It also has license agreement with Indiana University Research and Technology Corporation to develop and commercialize products for its HBV programs. The company was formerly known as Ventrus Biosciences, Inc. and changed its name to Assembly Biosciences, Inc. in June 2014. Assembly Biosciences, Inc. was incorporated in 2005 and is headquartered in South San Francisco, California.",Biotechnology,5482750.0,0.13154,13.48,20.04,7.68,-53997504.0,0.607,4.33,2.12,24.02,25.74,13.71,36.98,788.1,1046.0,1134.0,1489.0,1887.0,2213.0,2520.0,37.0,407.3,89.6,154.5,249.7,489.9,665.5,79.74,191.6,130.7,264.1,268.7,560.6,855.1,72.3,163.0,102.5,249.0,250.9,591.1,818.8,USD,Million
BNR,Burning Rock Biotech Limited,88198240.0,Healthcare,"Burning Rock Biotech Limited primarily develops and commercializes cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based tissue and liquid biopsy cancer therapy selection and prognosis prediction tests for various range of cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer using tissue and liquid biopsy samples. Its principal products include OncoCompass IO, a corresponding test for liquid biopsy samples; OncoScreen IO, a pan-cancer test for tissue samples; and OncoCompass Target, a ctDNA liquid biopsy-based test for NSCLC. In addition, the company provides ColonCore for assessing microsatellite loci related to MSI status and detecting mutations in genes associated with gastrointestinal cancers; and brPROPHET, a pre-operative ctDNA detection and post-operative MRD calling for relapsed patients. Further, it has development and commercialization agreement with Myriad Genetics, Inc. to in-license Myriad myChoice tumor testing in China; licensing agreement with Oncocyte Corporation to in-license DetermaRx, a risk stratification test for early stage lung cancer patients in China; and collaborations on clinical trials and research studies with AstraZeneca, Bayer, Johnson & Johnson, CStone, BeiGene, Abbisko Therapeutics, and IMPACT Therapeutics and Merck KGaA. Additionally, the company offers OncoMaster, an automatic NGS data analysis and report interpretation machine for in-hospital model. Burning Rock Biotech Limited was incorporated in 2014 and is headquartered in Guangzhou, China.",Diagnostics & Research,102675000.0,0.60972,0.8208,3.25,0.572,-518725184.0,0.232,2.6,15.43,-13.26,-20.31,-70.47,-11.74,29883.0,31306.0,35391.0,38112.0,41896.0,45126.0,47636.0,4454.0,3533.0,8539.0,5313.0,9028.0,8734.0,9358.0,0.0,0.0,0.0,0.0,10965.0,11449.0,11728.0,6063.0,4472.0,7078.0,8510.0,10655.0,11748.0,11963.0,USD,Million
DUET,DUET Acquisition Corp.,41972308.0,Financial Services,"DUET Acquisition Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses in technology sector. The company was incorporated in 2021 and is based in Kuala Lumpur, Malaysia.",Shell Companies,1673340.0,2.35453,10.96,11.83,10.4,44217628.0,0.06,0.0,-0.09,2.24,5.28,11.38,-0.36,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-0.006092,-0.4696,0.2228,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-0.006092,-1.289,-2.76,0.0,0.0,0.0,0.0,USD,Million
DRMAW,"Dermata Therapeutics, Inc.",0.0,Healthcare,"Dermata Therapeutics, Inc., a late-stage medical dermatology company, focuses on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. The company's lead product candidate is DMT310, which has completed Phase IIb clinical trial for treatment of moderate-to-severe acne; and Phase Ib proof of concept (POC) trial for Mild-to-Moderate Psoriasis, as well as is in a Phase 2 clinical trial for treatment of moderate-to-severe rosacea. It is also developing DMT410 that has completed Phase Ib POC trials for the treatment of anxillary hyperhidrosis and aesthetic conditions. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.",Biotechnology,0.0,0.0,0.0092,0.0092,0.0092,0.0,0.872,0.0,0.0,0.0,0.0,0.0,0.0,380.8,540.1,701.9,933.0,1243.0,1852.0,2898.0,-715.1,-554.1,-418.8,-703.5,-536.0,213.6,1004.0,-681.1,-537.3,-421.7,-494.3,-223.4,159.0,1034.0,-705.6,-564.2,-459.7,-536.2,-267.8,154.7,929.7,USD,Million
IRMD,IRADIMED CORPORATION,537468608.0,Healthcare,"IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices and related accessories, and disposables and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; MRI compatible patient vital signs monitoring system; and 3600 FMD1 with RALU ferromagnetic detection device. The company also provides non-magnetic IV poles, wireless remote displays/controls, side car pump modules, dose error reduction systems, and SpO2 monitoring with sensors and accessories. It serves hospitals, acute care facilities, and outpatient imaging centers. The company sells its products through direct field sales representatives, regional sales directors, clinical application specialists, and independent distributors. IRADIMED CORPORATION was incorporated in 1992 and is headquartered in Winter Springs, Florida.",Medical Devices,12664200.0,0.54903,42.44,51.037,36.12,489690464.0,0.855,4.87,-1.19,-3.92,12.64,4.26,-10.6,38.52,31.72,41.81,53.3,65.56,72.56,81.19,9.631,1.369,9.325,12.83,17.19,17.74,20.86,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.647,-0.7561,9.818,15.63,20.04,20.59,25.24,USD,Million
CFFI,C&F Financial Corporation,124601936.0,Financial Services,"C&F Financial Corporation operates as a bank holding company for Citizens and Farmers Bank that provides banking services to individuals and businesses. It operates through three segments: Community Banking, Mortgage Banking, and Consumer Finance. The Community Banking segment offers various banking services, including checking and savings deposit accounts, as well as business, real estate, development, mortgage, home equity, and installment loans. This segment also provides ATMs, Internet and mobile banking, peer-to-peer payment capabilities, and debit cards, as well as safe deposit box rentals, notary public, electronic transfer, and other customary bank services. The Mortgage Banking segment provides various residential mortgage loans; originates conventional mortgage loans, mortgage loans insured by the Federal Housing Administration, and mortgage loans guaranteed by the United States Department of Agriculture and the Veterans Administration; and ancillary mortgage loan production services to third parties for residential appraisals, as well as various mortgage origination activities. The Consumer Finance segment provides automobile loans. It also offers brokerage and wealth management services, and insurance products and services, as well as title and settlement agency. C&F Financial Corporation was founded in 1927 and is headquartered in Toano, Virginia.",Banks - Regional,3367620.0,0.37825,37.0,72.0,33.51,207482896.0,0.343,4.67,-23.79,-35.92,-30.06,-32.22,-45.74,278397.0,180366.0,157739.0,241392.0,210130.0,211406.0,208833.0,4026.0,-20305.0,7565.0,-2487.0,15239.0,13850.0,13524.0,36571.0,12041.0,37147.0,60362.0,42964.0,41918.0,42211.0,18791.0,-2848.0,22342.0,46044.0,27036.0,26346.0,26041.0,USD,Million
TCBS,"Texas Community Bancshares, Inc.",45188200.0,Financial Services,"Texas Community Bancshares, Inc. operates as the bank holding company for Mineola Community Bank, S.S.B. that provides loans and banking services to consumers and commercial customers in Mineola, Texas and the surrounding area, and the Dallas Fort Worth Metroplex. It generates a selection of deposit accounts, including savings accounts, checking accounts, certificates of deposit, and individual retirement accounts. The company also originates primarily one- to four-family residential mortgage loans, commercial real estate loans, and construction and land loans; and car, boat, share, unsecured loans, etc., as well as agricultural loans, commercial loans, and consumer and other loans. In addition, it invests in securities; and offers sweep account, safe deposit boxes, e-statement, cards, online banking, and mobile banking services. Texas Community Bancshares, Inc. was founded in 1934 and is headquartered in Mineola, Texas.",Banks - Regional,3187880.0,0.07971,14.175,15.24,9.38,97141544.0,-0.023,-1.68,-3.98,-0.64,11.19,-8.37,-0.74,14383.0,14461.0,18344.0,20028.0,17519.0,15740.0,17977.0,5017.0,5595.0,7769.0,8749.0,6510.0,4685.0,5824.0,6719.0,6825.0,9857.0,11065.0,8506.0,6934.0,8849.0,5723.0,5894.0,8960.0,10140.0,7331.0,5468.0,6857.0,USD,Million
BLBX,Blackboxstocks Inc.,8613794.0,Technology,"Blackboxstocks Inc. develops and markets financial technology and social media hybrid platform. It offers Blackbox System, a subscription-based software as a service that provides real-time proprietary analytics and news for stock and options traders. The company is headquartered in Dallas, Texas.",Software - Application,3226140.0,0.03526,2.67,4.25,1.6,8504953.0,0.351,2.69,3.09,-11.0,12.66,-24.15,-5.32,0.0,6.112,4.959,3.106,3.3,0.0,0.0,-0.3549,-2.616,-5.02,-4.664,-1.4,0.0,0.0,0.0,-0.8934,-4.37,-3.131,-0.4,0.0,0.0,0.0,-2.278,-4.546,-5.298,-1.4,0.0,0.0,USD,Million
HAO,Haoxi Health Technology Limited,155396592.0,Communication Services,"Haoxi Health Technology Limited, through its subsidiaries, provides online marketing solutions in China. It offers online marketing solutions, which include online short video marketing solutions to advertisers through its media partners; and customized marketing solutions by planning, producing, placing, and optimizing online ads to help its advertisers acquire, convert, and retain consumers on various online media platforms. The company places its ads through mainstream online short video platforms and social media platforms, such as Toutiao, Douyin, WeChat, and Sina Weibo. It serves advertiser client base primarily in the healthcare industry. The company was founded in 2018 and is based in Beijing, China.",Advertising Agencies,14970000.0,0.00055,4.91,8.83,4.03,144434624.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,29883.0,31306.0,35391.0,38112.0,41896.0,45126.0,47636.0,4454.0,3533.0,8539.0,5313.0,9028.0,8734.0,9358.0,0.0,0.0,0.0,0.0,10965.0,11449.0,11728.0,6063.0,4472.0,7078.0,8510.0,10655.0,11748.0,11963.0,USD,Million
EGBN,"Eagle Bancorp, Inc.",672244032.0,Financial Services,"Eagle Bancorp, Inc. operates as the bank holding company for EagleBank that provides commercial and consumer banking services primarily in the United States. The company also offers various commercial and consumer lending products comprising commercial loans for working capital, equipment purchases, real estate lines of credit, and government contract financing; asset based lending and accounts receivable financing; construction and commercial real estate loans; business equipment financing; consumer home equity lines of credit, personal lines of credit, and term loans; consumer installment loans, such as auto and personal loans; personal credit cards; and residential mortgage loans. In addition, it provides online and mobile banking services; checking and saving accounts; and other deposit services, including cash management services, business sweep accounts, lock boxes, remote deposit captures, account reconciliation services, merchant card services, safety deposit boxes, and automated clearing house origination, as well as after-hours depositories and ATM services. Further, the company offers insurance products and services through a referral program; and treasury management services. The company serves sole proprietors, small and medium-sized businesses, partnerships, corporations, and non-profit organizations and associations, as well as investors. Eagle Bancorp, Inc. was incorporated in 1997 and is headquartered in Bethesda, Maryland.",Banks - Regional,30186000.0,0.78455,22.24,31.97,16.72,1366575488.0,1.003,8.86,-1.02,-20.17,22.47,-14.13,-26.21,1677.0,1613.0,1817.0,2345.0,2608.0,2560.0,2665.0,674.0,567.8,873.0,1128.0,1161.0,1103.0,1143.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,942.6,896.4,1021.0,1485.0,1585.0,1632.0,1653.0,USD,Million
WHFCL,"WhiteHorse Finance, Inc. 7.875% Notes due 2028",0.0,0,0,0,0.0,0.0,0.0,27.41,24.21,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,67.07,61.7,72.14,87.53,103.3,98.72,94.16,30.84,31.68,30.09,15.68,20.41,41.28,38.49,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,USD,Million
UHG,"United Homes Group, Inc.",307158816.0,Consumer Cyclical,"UHG is a publicly traded residential builder headquartered in Columbia, SC. The company focuses on southeastern markets with 63 current active communities in South Carolina, North Carolina and Georgia. UHG employs a land-light operating strategy with a focus on the design, construction and sale of entry-level, first move up and second move up single-family houses. UHG currently designs, builds and sells detached single-family homes, and, to a lesser extent, attached single-family homes, including duplex homes and town homes in three major market regions in South Carolina: Midlands, Upstate, and Coastal, and also has a presence in Georgia and North Carolina. UHG seeks to operate its homebuilding business in high-growth markets, with substantial in-migrations and employment growth. Under its land-light lot operating strategy, UHG controls its supply of finished building lots through lot purchase agreements with third parties including its Land Development Affiliates, which provide UHG with the right to purchase finished lots after they have been developed by the applicable third party. This land-light operating strategy provides UHG with the ability to amass a pipeline of lots without the same risks associated with acquiring and developing raw land. As UHG reviews potential geographic markets into which it could expand its homebuilding business, either organically or through strategic acquisitions, it intends to focus on selecting markets with positive population and employment growth trends, favorable migration patterns, attractive housing affordability, low state and local income taxes, and desirable lifestyle and weather characteristics.",Residential Construction,11397600.0,0.39747003,6.33,18.7,4.79,403572512.0,0.656,-0.94,-4.67,-22.04,-4.38,-49.36,-24.91,19796.0,20841.0,21111.0,20688.0,20502.0,20546.0,20720.0,-1293.0,4467.0,2475.0,5764.0,8130.0,8748.0,8924.0,10960.0,12412.0,12044.0,12237.0,12602.0,12505.0,12744.0,10734.0,12155.0,11800.0,12011.0,12330.0,12122.0,12319.0,USD,Million
REGCP,Regency Centers Corporation,0.0,Real Estate,"Regency Centers is a preeminent national owner, operator, and developer of shopping centers located in suburban trade areas with compelling demographics. Our portfolio includes thriving properties merchandised with highly productive grocers, restaurants, service providers, and best-in-class retailers that connect to their neighborhoods, communities, and customers. Operating as a fully integrated real estate company, Regency Centers is a qualified real estate investment trust (REIT) that is self-administered, self-managed, and an S&P 500 Index member.",REIT - Retail,0.0,0.38474,23.04,25.25,22.38,8940318720.0,1.179,0.0,0.0,0.0,0.0,0.0,0.0,10918.0,16675.0,26914.0,26974.0,60922.0,111777.0,0.0,2796.0,4332.0,9752.0,4368.0,29760.0,57275.0,0.0,3227.0,5630.0,11215.0,5768.0,34480.0,71301.0,0.0,3735.0,6803.0,12690.0,9040.0,37134.0,72799.0,0.0,USD,Million
XNCR,"Xencor, Inc.",1162508160.0,Healthcare,"Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome; and Monjuvi for the treatment of patients with relapsed or refractory diffuse large B-cell lymphoma. It develops Plamotamab, a bispecific antibody, which is in Phase I clinical trial to treat non-Hodgkin lymphoma; Vudalimab, a bispecific antibody, which is in Phase II clinical trial to treat metastatic castration-resistant prostate cancer and other solid tumor types. The company is also developing XmAb306, which is in Phase I clinical trial to treat solid tumors; XmAb104, which is in Phase II clinical trial to treat patients with selected solid tumors; XmAb564 that is in Phase Ia clinical trial to treat autoimmune diseases; AMG 509, which is in Phase I clinical trial to treat prostate cancer; XmAb819 for patients with renal cell carcinoma; XmAb541 for the treatment of ovarian cancer; and XmAb662 which is in Phase I clinical trial to treat patients with solid tumors. In addition, the company develops VIR-3434, which is in Phase II clinical trial for patients with hepatitis B virus infection; and VIR-2482 that is in Phase 2 clinical trial to trat hepatitis B virus. The company develops AIMab7195 to reduce blood serum levels of IgE that mediates allergic responses and allergic disease; Obexelimab to treat autoimmune disease; and Xpro1595 to treat patients with Alzheimer's disease, and depression. It has a license agreement with Caris Life Sciences. Xencor, Inc. was incorporated in 1997 and is headquartered in Pasadena, California.",Biotechnology,61120300.0,1.05705,19.02,28.96,16.49,652553600.0,0.764,0.0,0.0,0.0,0.0,0.0,0.0,156.7,122.7,275.1,164.6,168.3,93.25,155.9,26.88,-69.33,82.63,-55.18,-126.1,-203.9,-171.5,18.12,-71.0,51.26,-73.67,-127.1,-180.5,-157.1,13.82,-76.8,43.77,-82.47,-138.6,-214.6,-188.0,USD,Million
FMNB,Farmers National Banc Corp.,473453312.0,Financial Services,"Farmers National Banc Corp. operates as a bank holding company for The Farmers National Bank of Canfield engages in the banking, trust, retirement consulting, insurance, and financial management businesses. It offers commercial and retail banking services, including checking, savings, and time deposit accounts; commercial, mortgage and installment, and home equity loans; home equity lines of credit, night depository, safe deposit box, money order, bank check, automated teller machine, Internet banking, travel card, E bond transaction, brokerage, and other services. The company also provides personal and corporate trust services in the areas of estate settlement, trust administration, employee benefit plans, and retirement services; property and casualty insurance products and services; and various insurance products through licensed representatives, as well as invests in municipal securities. The company was founded in 1887 and is headquartered in Canfield, Ohio.",Banks - Regional,37545900.0,0.39445,12.38,14.75,10.38,823178240.0,0.85,4.3,-3.05,-13.61,14.74,8.88,-14.33,14933.0,14540.0,14779.0,18449.0,21659.0,21542.0,21194.0,1511.0,1264.0,1640.0,2353.0,7797.0,2668.0,2843.0,5030.0,4947.0,4598.0,5643.0,6278.0,6950.0,7422.0,3442.0,3307.0,2926.0,3813.0,4294.0,4781.0,5113.0,GBP,Million
CHI,Calamos Convertible Opportunities and Income Fund,830481792.0,Financial Services,"Calamos Convertible Opportunities and Income Fund is a closed ended fixed income mutual fund launched by Calamos Investments LLC. It is managed by Calamos Advisors LLC. The fund invests in the fixed income markets of the United States. It primarily invests in a diversified portfolio of convertible securities and high yield corporate bonds rated Ba or lower by Moody's or BB or lower by Standard & Poor's. The fund employs both fundamental and quantitative analysis with a focus on such factors as financial soundness, ability to make interest and dividend payments, earnings and cash-flow forecast, and quality of management to create its portfolio. Calamos Convertible Opportunities and Income Fund was formed on April 17, 2002 and is domiciled in the United States.",Asset Management,74818200.0,0.55433,11.03,11.61,9.7,0.0,1.155,3.67,-4.17,4.45,6.67,6.04,6.47,22320.0,24540.0,28318.0,28541.0,34124.0,41361.0,51289.0,8318.0,6194.0,5582.0,6245.0,5240.0,10884.0,15788.0,7551.0,8589.0,10005.0,9472.0,8584.0,14921.0,20892.0,6079.0,7265.0,8457.0,7950.0,7057.0,13438.0,19246.0,USD,Million
ADXN,Addex Therapeutics Ltd,19052326.0,Healthcare,"Addex Therapeutics Ltd, a development-stage biopharmaceutical company, discovers, develops, and commercializes small-molecule pharmaceutical products for central nervous system (CNS) disorders in Switzerland. The company focuses on the discovery of G-protein coupled receptors. Its lead programs include Dipraglurant for the treatment of Parkinson's disease levodopa-induced dyskinesia, and dystonia; ADX71149 for epilepsy and undisclosed CNS disorders; and GABAB PAM for pain, anxiety, and addiction. It has license and collaboration agreement with Janssen Pharmaceuticals Inc.; Indivior PLC; and The CharcotMarieTooth Association. The company was formerly known as Addex Pharmaceuticals Ltd. Addex Therapeutics Ltd was founded in 2002 and is headquartered in Geneva, Switzerland.",Biotechnology,1068810.0,0.18326001,15.55,27.9,5.0,1990876160.0,1.759,-29.32,31.84,119.94,89.63,12.68,157.02,9480619.0,8767263.0,8729196.0,10264602.0,10881150.0,9449918.0,9059800.0,222546.0,87596.0,501613.0,583470.0,649124.0,569208.0,598215.0,1123020.0,1095041.0,986843.0,1278488.0,1274454.0,1222957.0,1303496.0,754976.0,661883.0,495180.0,738236.0,748144.0,753373.0,834056.0,JPY,Million
RGTIW,"Rigetti Computing, Inc.",0.0,Technology,"Rigetti Computing, Inc., through its subsidiaries, builds quantum computers and the superconducting quantum processors. The company offers cloud in a form of quantum processing unit, such as 9-qubit chip and Ankaa-2 system under the Novera brand name; and sells access to its quantum computers through quantum computing as a service. It also provides quantum cloud services that provides various range of support in programming, public or private clouds integration, and connectivity, as well as quantum operating system software that supports both public and private cloud architectures. In addition, the company offers professional services, such as algorithm development, benchmarking, quantum application programming, and software development. The company serves commercial enterprises, government organizations, and international government entities. It has operations in the United States and the United Kingdom. Rigetti Computing, Inc. was founded in 2013 and is headquartered in Berkeley, California.",Computer Hardware,0.0,0.0,0.2,0.2,0.1991,0.0,2.435,0.0,0.0,0.0,0.0,0.0,0.0,8.196,13.1,12.01,16.1,30.87,0.0,0.0,0.0,-71.52,-75.11,-68.51,-66.13,0.0,0.0,-29.48,-51.87,-51.47,-49.52,-47.08,0.0,0.0,-34.13,-58.89,-58.9,-51.0,-41.6,0.0,0.0,USD,Million
SPNS,Sapiens International Corporation N.V.,1734417280.0,Technology,"Sapiens International Corporation N.V. provides software solutions for the insurance industry in North America, the United Kingdom, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides various solutions for property and casualty commercial and personal lines, life and pensions, and reinsurance fields. It offers IDITSuite, an AI powered, end-to-end insurance software; DigitalSuite, a cloud-native, future-proof digital engagement platform; IDITGo, a pre-configured, data-enriched insurance launch and accelerator platform solutions; consultancy services for property and casualty commercial lines; and Tia Enterprise solution for customer engagement. The company also provides CoreSuite, an end-to-end cloud and digital PAS for individual and group products across life, health, wealth, and pensions; CustomerConnect, a dynamic self-service and persona-based portal to engage with insureds; AgentConnect, a portal for agents and brokers to focus on sales enablement, customer retention, and increasing customer value; and ReinsuranceMaster, a reinsurance automation software that provides insurers full financial control and flexibility over their entire reinsurance process. The company was founded in 1982 and is headquartered in Holon, Israel.",Software - Application,55733200.0,0.3151,31.12,35.33,19.91,1622336384.0,1.171,2.88,-1.46,11.14,23.98,51.07,7.53,77147.0,73620.0,57350.0,60530.0,61860.0,63594.0,66509.0,9431.0,5590.0,5743.0,1639.0,7502.0,8041.0,8643.0,18246.0,15379.0,0.0,14739.0,15447.0,15866.0,16690.0,12187.0,8684.0,0.0,9937.0,11052.0,11623.0,12625.0,USD,Million
NTNX,"Nutanix, Inc.",14921155584.0,Technology,"Nutanix, Inc. provides an enterprise cloud platform in North America, Europe, the Asia Pacific, the Middle East, Latin America, and Africa. The company offers hyperconverged infrastructure software stack that converges virtualization, storage, and networking services into a turnkey solution; Acropolis Hypervisor, an enterprise-grade virtualization solution; flow virtual networking and flow network security, which offers services to visualize the network, automate common network operations, and build virtual private networks; Nutanix Kubernetes Engine for automated deployment and management of Kubernetes clusters to simplify the provisioning, operations, and lifecycle management of cloud-native environments, applications, and microservices; and Nutanix Cloud Clusters. It also provides Nutanix Cloud Management that provides management, capacity planning, operational analytics, automated remediation, self-service, and one-click administration; cloud governance; and automation services that streamline application lifecycle management, provide self-service for infrastructure and applications, and deliver multicloud orchestration. In addition, the company offers Nutanix Files, an enterprise-grade network file system and server message block files services; Nutanix Objects, a S3-compatible object services; Nutanix Data Lens, a data security governance solution; and Nutanix database service that provides automated database management to simplify database administration and to manage database copies. Further, it provides product support, and consulting and implementation services. The company serves customers in a range of industries, including automotive, consumer goods, education, energy, financial services, healthcare, manufacturing, media, public sector, retail, technology, and telecommunications, as well as service providers. Nutanix, Inc. was incorporated in 2009 and is headquartered in San Jose, California.",Software - Infrastructure,244328992.0,0.83769,60.89,66.99,23.345,14598715392.0,1.277,0.3,-4.29,7.6,70.27,152.76,27.68,1236.0,1308.0,1394.0,1581.0,1863.0,2140.0,2493.0,-621.2,-872.9,-1034.0,-797.5,-254.6,-65.9,40.3,-196.7,-361.3,-186.7,2.141,237.4,358.8,447.8,-274.3,-455.0,-281.0,-85.81,161.0,284.5,377.4,USD,Million
PROV,"Provident Financial Holdings, Inc.",90047104.0,Financial Services,"Provident Financial Holdings, Inc. operates as the holding company for Provident Savings Bank, F.S.B. that provides community banking services to consumers and small to mid-sized businesses in the Inland Empire region of Southern California. The company's deposit products include checking, savings, and money market accounts, as well as time deposits; and loan portfolio consists of single-family, multi-family, commercial real estate, construction, mortgage, commercial business, and consumer loans. It also offers investment services comprising the sale of investment products, such as annuities and mutual funds; and trustee services for real estate transactions. The company operates through full-service banking offices in Riverside County and San Bernardino County. Provident Financial Holdings, Inc. was founded in 1956 and is headquartered in Riverside, California.",Banks - Regional,6926700.0,0.52535,13.0,15.4,10.16,287447040.0,0.393,-2.69,-4.9,-6.27,5.69,-4.2,3.09,481.4,874.4,1452.0,2241.0,3056.0,3974.0,0.0,-141.8,-92.63,-234.8,-183.2,89.33,219.3,0.0,-42.61,101.0,239.2,432.9,768.7,1025.0,0.0,-65.64,62.35,196.2,355.6,660.3,896.1,0.0,USD,Million
ELTX,"Elicio Therapeutics, Inc.",94544248.0,Healthcare,"Elicio Therapeutics, Inc., a clinical-stage biotechnology company, develops a pipeline of novel immunotherapies for the treatment of cancer, infectious, and other diseases. The company's lead product candidate is ELI-002, an AMP therapeutic vaccine for the treatment of KRAS-driven cancers that is in Phase II clinical trial. It is also developing ELI-004, an AMP-modified CpG adjuvant and a component of ELI-002; ELI-007, a lymph node targeted AMP-peptide vaccine for mutant BRAF-driven cancers; and ELI-008, a multivalent lymph node targeted AMP-peptide vaccine for mutant TP53-expressing cancers. The company is headquartered in Boston, Massachusetts.",Biotechnology,10221000.0,0.05308,9.25,24.39,2.96,88567376.0,0.0,-0.54,34.06,180.3,52.39,20.84,10.91,380.8,540.1,701.9,933.0,1243.0,1852.0,2898.0,-715.1,-554.1,-418.8,-703.5,-536.0,213.6,1004.0,-681.1,-537.3,-421.7,-494.3,-223.4,159.0,1034.0,-705.6,-564.2,-459.7,-536.2,-267.8,154.7,929.7,USD,Million
IRON,"Disc Medicine, Inc.",673791296.0,Healthcare,"Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States. The company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, primarily heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for the treatment of erythropoietic porphyrias, including erythropoietic protoporphyria, X-linked protoporphyria, and diamond-blackfan anemia; DISC-0974 for the treatment of anemia of myelofibrosis, and anemia of chronic kidney disease; and DISC-3405 for the treatment of polycythemia vera, and other hematologic disorders. The company's preclinical programs include DISC-0998, for the treatment of anemia associated with inflammatory diseases. Disc Medicine, Inc. was founded in 2017 and is headquartered in Watertown, Massachusetts.",Biotechnology,24681000.0,0.85052,27.3,77.6,25.6,315511072.0,0.0,-9.84,-54.12,-55.94,-35.26,-8.54,-52.74,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-35.97,-46.83,-76.43,-111.7,-137.4,0.0,0.0,0.0,0.0,-91.02,-110.3,-156.6,0.0,0.0,0.0,-47.48,-91.12,-132.9,-146.3,0.0,0.0,USD,Million
SCOR,"comScore, Inc.",68854568.0,Communication Services,"comScore, Inc. operates as an information and analytics company that measures audiences, consumer behavior, and advertising across media platforms in the United States, Europe, Latin America, Canada, and internationally. The company provides digital ad solutions, including Media Metrix Multi-Platform and Mobile Metrix, which measure websites and applications on computers, smartphones, and tablets; Video Metrix that delivers measurement of digital video consumption; Plan Metrix, which offers understanding of consumer lifestyle; Total Home Panel Suite, which capture OTT, connected TV, and IOT device usage and content consumption; CCR, which enhances validated campaign essentials verification of mobile and desktop video campaigns; XMedia Enhanced, which provides a deduplicated view of national programming content; Comscore marketing solutions; Lift Models, which measures the impact of advertising on a brand; Survey Analytics, which measure various consumer insights including brand health metrics; and Activation Solutions, including audience activation and content activation. The company's cross platform solutions products and services comprises Comscore TVNational that helps customers understand the performance of network advertising campaigns; Comscore TVLocal allows customers to understand consumer viewing patterns and characteristics; OnDemand Essentials that provides transactional tracking and reporting; Movie Solutions; and Hollywood Software Suite. In addition, it offers custom solutions for planning, optimization, and evaluation of advertising campaigns and brand protection. Further, the company provides products that measure movie viewership and box office results by capturing movie ticket sales in real time or near real time. It serves digital publishers, television networks, movie studios, content owners, brand advertisers, agencies, and technology providers. The company was incorporated in 1999 and is headquartered in Reston, Virginia.",Internet Content & Information,4755150.0,0.35597,14.48,22.0,9.6,284958624.0,1.092,-1.76,-5.05,-22.44,14.77,-32.96,-13.29,388.6,356.0,367.0,376.4,371.3,379.1,397.1,-339.0,-47.92,-62.66,-82.07,-95.63,6.1,0.0,6.215,32.3,31.87,37.01,44.03,51.12,56.15,-310.5,-21.28,-28.86,-74.87,-73.6,13.35,0.0,USD,Million
GLYC,"GlycoMimetics, Inc.",119555496.0,Healthcare,"GlycoMimetics, Inc., a biotechnology company, focuses on the discovery and development of therapies for cancers and inflammatory diseases in the United States. It develops uproleselan, an E-selectin antagonist, which is used in combination with chemotherapy to treat acute myeloid leukemia (AML), as well as completed phase 3 trial to treat relapsed/refractory AML. The company also develops various other programs, including GMI-1687, an antagonist of E-selectin to treat vaso-occlusive crisis; and GMI-2093, a galectin-3 carbohydrate-binding protein. In addition, its portfolio comprises GMI-1359, which targets e-selectin and a chemokine receptor for the treatment of osteosarcoma. The company has a cooperative research and development agreement with the National Cancer Institute; and a collaboration and license agreement with Apollomics (Hong Kong) Limited for the development and commercialization of uproleselan and GMI-1687. GlycoMimetics, Inc. was incorporated in 2003 and is headquartered in Rockville, Maryland.",Biotechnology,64450400.0,0.53423,1.855,3.53,1.11,78571040.0,2.193,-18.64,-34.22,-39.58,58.55,32.5,-21.4,0.0,10.16,1.16,0.075,0.01,0.0,28.74,-57.89,-51.03,-63.43,-46.69,-36.9,-40.64,-29.97,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-61.39,-51.51,-63.45,-47.4,-39.28,-41.44,-30.34,USD,Million
OCUL,"Ocular Therapeutix, Inc.",743134976.0,Healthcare,"Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology in the United States. The company markets DEXTENZA, a dexamethasone ophthalmic insert to treat post-surgical ocular inflammation and pain following ophthalmic surgery, as well as allergic conjunctivitis. It is developing AXPAXLI, an axitinib intravitreal implant that is in phase 3 trials for the treatment of wet age-related macular degeneration and other retinal diseases; PAXTRAVA, a travoprost intracameral implant, which is in phase 2 clinical trials for the treatment of open-angle glaucoma or ocular hypertension; OTX-CSI, a cyclosporine intracanalicular insert that has completed phase 2 clinical trials for the treatment of dry eye disease; and OTX-DED, a dexamethasone intracanalicular insert, which is in phase 2 clinical trials for the short-term treatment of the signs and symptoms of dry eye disease. In addition, the company offers modulator for intermediate and late dry age-related macular degeneration; and gene delivery for inherited retinal degenerations and protein biofactory indications. The company has a strategic collaboration with Regeneron Pharmaceuticals, Inc. (Regeneron) for the development and commercialization of products using the company's sustained-release hydrogel in combination with Regeneron's large molecule VEGF-targeting compounds for the treatment of retinal diseases; and AffaMed Therapeutics Limited for the development and commercialization of DEXTENZA and OTX-TIC. Ocular Therapeutix, Inc. was incorporated in 2006 and is headquartered in Bedford, Massachusetts.",Biotechnology,148627008.0,0.50067,4.645,11.31,1.995,577956480.0,1.322,-38.72,-50.64,15.84,100.22,-25.08,4.15,4.227,17.4,43.52,51.49,58.44,68.34,84.72,-86.37,-155.6,-6.553,-71.04,-80.74,-101.1,-108.1,-83.27,-60.07,-75.62,-76.54,-79.4,-85.28,1422.0,-85.8,-62.85,-78.04,-78.65,-82.38,-99.61,-104.9,USD,Million
IMVT,"Immunovant, Inc.",4184438016.0,Healthcare,"Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops batoclimab, a novel fully human monoclonal antibody that target the neonatal fragment crystallizable receptor for the treatment of myasthenia gravis, thyroid eye disease, chronic inflammatory demyelinating polyneuropathy, and Graves diseases, as well as warm autoimmune hemolytic anemia. The company is headquartered in New York, New York. Immunovant, Inc. operates as a subsidiary of Roivant Sciences Ltd.",Biotechnology,145292992.0,0.47619998,28.8,45.58,15.9,3493806592.0,0.697,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,14.41,0.0,-66.39,-107.4,-156.7,-211.0,-249.6,-275.7,0.0,0.0,-108.1,-155.9,-218.1,-259.4,-259.5,0.0,-66.08,-108.1,-156.0,-218.3,-266.4,-291.2,0.0,USD,Million
OLLI,"Ollie's Bargain Outlet Holdings, Inc.",4584706048.0,Consumer Defensive,"Ollie's Bargain Outlet Holdings, Inc. operates as a retailer of brand name merchandise in the United States. The company offers housewares, bed and bath, food, floor coverings, health and beauty aids, books and stationery, toys, and electronics; and other products, including hardware, candy, clothing, sporting goods, pet and lawn, and garden products. It provides its products primarily under the Ollie's, Ollie's Bargain Outlet, Good Stuff Cheap, Ollie's Army, Real Brands Real Cheap!, Real Brands! Real Bargains, Sarasota Breeze, Steelton Tools, American Way, and Middleton Home names. The company was formerly known as Bargain Holdings, Inc. and changed its name to Ollie's Bargain Outlet Holdings, Inc. in March 2015. The company was founded in 1982 and is headquartered in Harrisburg, Pennsylvania.",Discount Stores,61366700.0,1.05018,74.71,84.38,52.93,4720216576.0,0.746,5.0,-5.86,4.87,0.27,14.15,-1.55,481.4,874.4,1452.0,2241.0,3056.0,3974.0,0.0,-141.8,-92.63,-234.8,-183.2,89.33,219.3,0.0,-42.61,101.0,239.2,432.9,768.7,1025.0,0.0,-65.64,62.35,196.2,355.6,660.3,896.1,0.0,USD,Million
STKS,"The ONE Group Hospitality, Inc.",166874304.0,Consumer Cyclical,"The ONE Group Hospitality, Inc., a restaurant company, develops, owns, operates, manages, and licenses restaurants and lounges worldwide. It operates through STK, Kona Grill, and ONE Hospitality segments. The company also provides turn-key food and beverage services for hospitality venues, including hotels, casinos, and other locations. Its hospitality food and beverage solutions include developing, managing, and operating restaurants, bars, rooftops, pools, banqueting, catering, private dining rooms, room service, and mini bars; and offers hospitality advisory and consulting services. The company operates restaurants primarily under the STK and Kona Grill brands. The ONE Group Hospitality, Inc. was founded in 2004 and is based in Denver, Colorado.",Restaurants,31308500.0,0.44439,5.33,8.07,3.21,344173472.0,2.441,0.57,33.92,22.25,22.39,-33.38,-12.91,28593.0,28523.0,30435.0,34250.0,36787.0,38257.0,39789.0,5192.0,2375.0,11965.0,7044.0,4582.0,5259.0,5873.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,13110.0,13467.0,13865.0,15087.0,16471.0,17266.0,17721.0,USD,Million
ASO,"Academy Sports and Outdoors, Inc.",4373594112.0,Consumer Cyclical,"Academy Sports and Outdoors, Inc., through its subsidiaries, operates as a sporting goods and outdoor recreational retailer in the United States. The company outdoor division comprises camping products, such as coolers and drinkware, and camping accessories and equipment,; fishing products, including marine equipment and fishing rods, reels, and baits and equipment; and hunting products, which includes firearms, ammunition, archery and archery equipment, camouflage apparel, waders, shooting accessories, gun safes, optics, airguns, and hunting equipment. Its sports and recreation division offers fitness equipment, fitness accessories, and nutrition supplies; team and specialty sports equipment, including baseball, football, basketball, soccer, golf, racket sports, volleyball, backpacks, and sports bags; recreation products, which includes patio furniture, outdoor cooking, trampolines, play sets, watersports, and pet equipment, as well as wheeled goods including bicycles, skateboards, and other ride-on toys; and electronics and watches, as well as front-end products, such as consumables, batteries, etc. The company's apparel division provides outdoor and seasonal apparel, denim, work apparel, graphic t-shirts, and accessories; boys and girls outdoor, and athletic apparel; sporting and fitness apparel; and professional and collegiate team licensed apparel and accessories. Its footwear division offers casual shoes, slippers, seasonal footwear, and socks; work and western boots, shoes, and hunting footwear; boys and girls footwear; athletic footwear, such as running shoes, athletic lifestyle, and training shoes; and team and specialty sports footwear, and slides. The company sells its products under the Academy Sports + Outdoors, Magellan Outdoors, BCG, O'rageous, Game Winner, Outdoor Gourmet, and Freely brand names. Academy Sports and Outdoors, Inc. was founded in 1938 and is headquartered in Katy, Texas.",Specialty Retail,73791000.0,1.06213,59.06,75.73,42.825,5743154176.0,1.352,2.45,-8.65,-9.0,34.93,-13.48,-10.52,22320.0,24540.0,28318.0,28541.0,34124.0,41361.0,51289.0,8318.0,6194.0,5582.0,6245.0,5240.0,10884.0,15788.0,7551.0,8589.0,10005.0,9472.0,8584.0,14921.0,20892.0,6079.0,7265.0,8457.0,7950.0,7057.0,13438.0,19246.0,USD,Million
CYCN,"Cyclerion Therapeutics, Inc.",8265790.0,Healthcare,"Cyclerion Therapeutics, Inc., a biopharmaceutical company, develops treatments for serious diseases. It is developing Olinciguat, an orally administered vascular soluble guanylate cyclase (sGC) stimulator, which is in Phase 2 clinical trial to out-license for cardiovascular diseases; and Praliciguat, a systemic sGC stimulator that is licensed to Akebia Therapeutics, Inc. for the treatment of rare kidney disease. The company was incorporated in 2018 and is headquartered in Cambridge, Massachusetts.",Biotechnology,2710100.0,0.41341,2.77,6.75,1.75,-537529.0,1.83,0.0,0.0,0.0,0.0,0.0,0.0,380.8,540.1,701.9,933.0,1243.0,1852.0,2898.0,-715.1,-554.1,-418.8,-703.5,-536.0,213.6,1004.0,-681.1,-537.3,-421.7,-494.3,-223.4,159.0,1034.0,-705.6,-564.2,-459.7,-536.2,-267.8,154.7,929.7,USD,Million
ANY,Sphere 3D Corp.,20465744.0,Technology,"Sphere 3D Corp. engages in the bitcoin mining business. It is involved with digital asset mining pool operators to provide computing power to the mining pools. The company is based in Stamford, Connecticut.",Software - Application,17796300.0,0.04381,1.15,4.09,0.571,33673776.0,2.797,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.641,0.0,29.51,35.05,0.0,0.0,-7.272,0.0,-260.9,0.0,0.0,0.0,0.0,0.0,-17.51,0.0,0.0,0.0,0.0,0.0,0.0,-24.6,0.0,-40.41,-27.03,0.0,0.0,CAD,Million
IVCAW,Investcorp India Acquisition Corp,0.0,Financial Services,"Investcorp India Acquisition Corp does not have significant operations. It intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or other similar business combination with one or more businesses. The company was formerly known as Investcorp Acquisition Corp. and changed its name to Investcorp India Acquisition Corp in January 2022. Investcorp India Acquisition Corp was incorporated in 2021 and is based in George Town, the Cayman Islands.",Shell Companies,0.0,0.0,0.0699,0.0699,0.065,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1235632.0,1370907.0,1526666.0,1612715.0,1814561.0,2068244.0,2256265.0,8622.0,144881.0,204105.0,316760.0,502324.0,552578.0,643833.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,538755.0,619170.0,700144.0,752924.0,837130.0,836718.0,1052110.0,INR,Million
FITBO,Fifth Third Bancorp,0.0,Financial Services,"Fifth Third Bancorp operates as the bank holding company for Fifth Third Bank, National Association that engages in the provision of a range of financial products and services in the United States. It operates through three segments: Commercial Banking, Consumer and Small Business Banking, and Wealth and Asset Management. The Commercial Banking segment offers credit intermediation, cash management, and financial services; lending and depository products; and cash management, foreign exchange and international trade finance, derivatives and capital markets services, asset-based lending, real estate finance, public finance, commercial leasing, and syndicated finance for business, government, and professional customers. The Consumer and Small Banking segment provides a range of deposit and loan products to individuals and small businesses; home equity loans and lines of credit; credit cards; and cash management services. This segment also engages in the residential mortgage that include origination, retention and servicing of residential mortgage loans, sales and securitizations of loans, and hedging activities; indirect lending, including extending loans to consumers through automobile dealers, motorcycle dealers, powersport dealers, recreational vehicle dealers, and marine dealers; and home improvement and solar energy installation loans through contractors and installers. The Wealth & Asset Management segment provides various wealth management services for individuals, companies, and not-for-profit organizations. It offers retail brokerage services to individual clients; and broker dealer services to the institutional marketplace. This segment also provides wealth planning, investment management, banking, insurance, and trust and estate services; and advisory services for institutional clients comprising middle market businesses, non-profits, states, and municipalities. The company was founded in 1858 and is headquartered in Cincinnati, Ohio.",Banks - Regional,0.0,0.20950001,22.03,23.99,17.58,31790379008.0,1.271,0.0,0.0,0.0,0.0,0.0,0.0,8350.0,7624.0,7900.0,8391.0,8733.0,8652.0,9058.0,2419.0,1323.0,2659.0,2330.0,2212.0,2251.0,2453.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3690.0,2953.0,3152.0,3672.0,3528.0,3650.0,3913.0,USD,Million
SWVL,Swvl Holdings Corp.,77899656.0,Technology,"Swvl Holdings Corp. provides mass transit ridesharing services. It offers B2C Swvl Retail, which provides riders with a network of minibuses and other vehicles running on fixed or semi-fixed routes within cities; Swvl Travel that allows riders to book rides on long-distance intercity routes on vehicle available through the Swvl platform or through third-party services; and Swvl Business, a transport as a service enterprise product for businesses, schools, municipal transit agencies, and other customers. Swvl Holdings Corp. was founded in 2017 and is headquartered in Dubai, the United Arab Emirates.",Software - Application,6791600.0,0.0063300002,11.47,21.94,0.62,76503288.0,0.636,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3183.0,3970.0,0.0,0.0,0.0,0.0,524.0,224.8,858.6,0.0,0.0,0.0,0.0,0.0,1502.0,1972.0,0.0,0.0,0.0,0.0,0.0,1348.0,1782.0,0.0,0.0,0.0,0.0,USD,Million
XRTX,XORTX Therapeutics Inc.,8411041.0,Healthcare,"XORTX Therapeutics Inc., a late stage clinical pharmaceutical company, engages in the development and commercialization of therapies to treat progressive kidney diseases, diabetes, insulin resistance, metabolic syndrome, diabetes, diabetic nephropathy, and infection. It develops XRx-008, a late clinical stage program therapy for autosomal dominant polycystic kidney disease; XRx-101, an uric acid lowering agent used to treat patients infected with the coronavirus COVID-19 infection and acute kidney injury (AKI) associated health consequences; and XRX-225, a program for treatment of type 2 diabetic nephropathy. The company has a collaboration and license agreements with the Icahn School of Medicine to study the incidence of AKI and hyperuricemia in patients hospitalized with COVID-19; and with the University of Florida Research Foundation, Inc. XORTX Therapeutics Inc. is based in Alberta Beach, Canada.",Biotechnology,2898560.0,0.23945999,2.9018,67.716,1.98,4974901.0,-0.151,0.0,0.0,0.0,0.0,0.0,0.0,1449.0,1483.0,1686.0,1936.0,2328.0,2699.0,2818.0,-104.5,514.8,475.8,727.3,984.8,1195.0,1231.0,-141.7,643.5,605.8,1031.0,1238.0,1398.0,1437.0,-187.6,593.6,555.9,979.7,1185.0,1436.0,1475.0,USD,Million
VSAC,Vision Sensing Acquisition Corp.,49816200.0,Financial Services,"Vision Sensing Acquisition Corp. does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It intends to focus on companies with operations in vision sensing technologies, including hardware chip solutions, VST-related application software, artificial intelligence, and other peripheral technologies that assist to integrate and/or supplement VST applications. The company was incorporated in 2021 and is based in Miami, Florida. Vision Sensing Acquisition Corp. operates as a subsidiary of Vision Sensing LLC.",Shell Companies,1820760.0,0.28911,11.45,11.85,10.5,49816260.0,0.023,0.35,2.97,3.62,8.53,15.31,3.62,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-0.848,-0.1474,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-0.8663,-1.63,0.0,0.0,0.0,0.0,0.0,USD,Million
MOGO,Mogo Inc.,45873880.0,Technology,"Mogo Inc. operates as a digital finance company in Canada, Europe, and internationally. The company's digital solutions help build wealth and achieve financial freedom. It provides MogoTrade, a stock trading app; Moka; and MogoMoney that provides online personal loans. The company also offers digital loans and mortgages; and operates a digital payments platform that powers next-generation card programs for both global corporations and fintech companies in Europe and Canada. Mogo Inc. is headquartered in Vancouver, Canada.",Software - Infrastructure,24326400.0,0.16346,1.88,2.955,0.95,118527672.0,3.515,3.3,-2.08,29.66,43.51,-3.59,2.17,59.8,44.24,57.52,68.95,65.22,71.33,80.34,-10.8,-13.44,-33.21,-165.7,-17.89,-30.24,-25.1,7.2,11.6,-11.11,-12.23,7.669,7.009,11.32,-3.654,1.139,-35.53,-33.58,-3.876,-13.78,-8.253,CAD,Million
OZKAP,Bank OZK,0.0,Financial Services,"Bank OZK provides various retail and commercial banking services for individuals and businesses in the United States. The company offers deposit services, including non-interest bearing checking, interest bearing transaction, business sweep, savings, money market, individual retirement, and other accounts, as well as time and reciprocal deposits. It also provides trust and wealth services, such as personal trusts, custodial accounts, investment management accounts, and retirement accounts, as well as corporate trust services, including trustee, paying agent and registered transfer agent services, and other related services. In addition, the company offers treasury management services comprising automated clearing house, wire transfer, transaction reporting, wholesale lockbox, remote deposit capture, automated credit line transfer, reconciliation, positive pay, commercial card, and other services, as well as zero balance and investment sweep accounts. Further, it provides real estate, consumer, small business, indirect recreational vehicle and marine, equipment, agricultural, commercial and industrial, government guaranteed, lines of credit, homebuilder, and affordable housing loans; lender and structured, business aviation, and subscription financing services; and mortgage and other lending products. Additionally, the company offers ATMs; telephone, online, and mobile banking services; credit and debit cards; safe deposit boxes; and other products and services. The company was formerly known as Bank of the Ozarks and changed its name to Bank OZK in July 2018. Bank OZK was founded in 1903 and is headquartered in Little Rock, Arkansas.",Banks - Regional,0.0,0.19634001,16.71,18.0,12.765,583277760.0,1.24,0.0,0.0,0.0,0.0,0.0,0.0,996.1,999.3,1110.0,1257.0,1562.0,1662.0,1720.0,425.9,291.9,579.0,547.5,674.6,708.4,738.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,595.0,585.8,679.7,805.0,1032.0,1126.0,1125.0,USD,Million
IIIV,"i3 Verticals, Inc.",784256064.0,Technology,"i3 Verticals, Inc. provides integrated payment and software solutions primarily to the public sector and healthcare markets in the United States. It operates in two segments, Software and Services, and Merchant Services. The company offers payment processing services that enables upper and lower court case management, collections, finance and accounting, motor vehicle and carrier registration, e-filing and taxation, license plate inventory, property tax management, utility billing, professional licensing, document workflow, and law enforcement software; assists public schools in completing payment processing functions, including accepting payments for online or at school lunches, and school activities. It also provides software platforms, such as electronic healthcare records and revenue cycle management solutions; insurance adjudication, patient engagement platforms, billing, scheduling, and integrated payments solutions; and workflow software and associated professional services to medical insurance payers. In addition, the company engages in software licenses and subscriptions, transaction-based fees, ongoing software maintenance and support, and other software-related solutions; and payment processing and gateway fees, as well as other related fixed transaction or service fees. Further, it sells equipment, and offers non-software related professional services. The company offers its solutions to clients through direct sales force; distribution partners comprising independent software vendors, independent sales organizations, and value-added resellers. i3 Verticals, Inc. was founded in 2012 and is headquartered in Nashville, Tennessee.",Software - Infrastructure,23279200.0,0.9282,23.46,25.7,17.54,1028644352.0,1.576,4.08,5.63,20.18,22.25,-3.38,10.82,137.6,151.0,224.7,317.9,370.2,394.0,426.7,-3.045,-0.419,-4.457,-17.1,-0.811,9.128,18.57,38.74,38.56,55.41,79.54,100.4,110.8,123.9,35.75,34.84,50.94,74.25,92.04,100.1,111.9,USD,Million
JFIN,Jiayin Group Inc.,346805760.0,Communication Services,"Jiayin Group Inc. provides online consumer finance services in the People's Republic of China. The company operates a fintech platform that facilitates transparent, secure, and fast connections between individual borrowers and financial institutions funding partners. It also offers referral services for investment products offered by the financial service providers; and software development, risk control, marketing support, and IT assistance services. The company was founded in 2011 and is headquartered in Shanghai, the People's Republic of China.",Internet Content & Information,53685100.0,0.00871,6.46,8.19,3.9,1056729984.0,0.957,1.41,-12.35,17.67,33.75,46.49,24.71,43165.0,44611.0,63495.0,55554.0,54041.0,53021.0,52722.0,8010.0,9769.0,21094.0,12420.0,10058.0,12209.0,11907.0,21197.0,23902.0,37720.0,26272.0,23892.0,24936.0,24897.0,16813.0,19623.0,33023.0,20508.0,15498.0,18382.0,17579.0,USD,Million
BREA,Brera Holdings PLC,17041360.0,Communication Services,"Brera Holdings PLC develops, manages, and operates football clubs. The company operates a football club under the Brera FC brand name. Brera Holdings PLC was founded in 2000 and is based in Dublin, Ireland.",Entertainment,4560000.0,0.00321,1.4,3.2,0.526,11638228.0,0.0,9.88,-4.11,-35.19,35.92,-55.56,113.54,0.2148,0.4202,0.1624,0.0,0.0,0.0,0.0,0.002508,-0.0871,-1.227,0.0,0.0,0.0,0.0,-0.008822,-0.002635,-1.223,0.0,0.0,0.0,0.0,-0.01,-0.00709,-1.227,0.0,0.0,0.0,0.0,in,Million
SFST,"Southern First Bancshares, Inc.",228531120.0,Financial Services,"Southern First Bancshares, Inc. operates as the bank holding company for Southern First Bank that provides commercial, consumer, and mortgage loans to the general public in South Carolina, North Carolina, and Georgia. The company accepts various deposit products that include checking accounts, commercial checking accounts, and savings accounts, as well as other time deposits, including daily money market accounts and long-term certificates of deposit. Its loan portfolio comprises commercial real estate loans; construction real estate loans; commercial business loans for various lines of businesses, such as the manufacturing, service industry, and professional service areas; consumer real estate and home equity loans; and other consumer loans, including secured and unsecured installment loans and revolving lines of credit. In addition, the company provides other bank services, such as internet banking, cash management, safe deposit boxes, direct deposit, automatic drafts, bill payment, and mobile banking services. Southern First Bancshares, Inc. was incorporated in 1999 and is headquartered in Greenville, South Carolina.",Banks - Regional,8156000.0,0.81194,28.02,39.36,20.75,337571136.0,0.773,0.0,0.0,0.0,0.0,0.0,0.0,21419.0,20375.0,23113.0,29279.0,25253.0,26913.0,28247.0,4739.0,3119.0,2393.0,3524.0,3976.0,4389.0,4756.0,8178.0,8889.0,9123.0,9284.0,10351.0,11632.0,12436.0,5140.0,5371.0,5558.0,5621.0,5826.0,6842.0,7604.0,USD,Million
AFRM,"Affirm Holdings, Inc.",10053198848.0,Technology,"Affirm Holdings, Inc. operates a platform for digital and mobile-first commerce in the United States, Canada, and internationally. The company's platform includes point-of-sale payment solution for consumers, merchant commerce solutions, and a consumer-focused app. Its commerce platform, agreements with originating banks, and capital markets partners enables consumers to pay for a purchase over time with terms ranging up to 60 months. The company has active merchants covering small businesses, large enterprises, direct-to-consumer brands, brick-and-mortar stores, and companies with an omni-channel presence. Its merchants represent a range of industries, including sporting goods and outdoors, furniture and homewares, travel and ticketing, apparel, accessories, consumer electronics, and jewelry. Affirm Holdings, Inc. was founded in 2012 and is headquartered in San Francisco, California.",Software - Infrastructure,259564000.0,0.84262,32.08,52.48,8.8,14365764608.0,3.577,0.0,0.0,0.0,0.0,0.0,0.0,481.4,874.4,1452.0,2241.0,3056.0,3974.0,0.0,-141.8,-92.63,-234.8,-183.2,89.33,219.3,0.0,-42.61,101.0,239.2,432.9,768.7,1025.0,0.0,-65.64,62.35,196.2,355.6,660.3,896.1,0.0,USD,Million
DNLI,Denali Therapeutics Inc.,2293466368.0,Healthcare,"Denali Therapeutics Inc., a biopharmaceutical company, develops a portfolio of product candidates engineered to cross the blood-brain barrier for neurodegenerative diseases and lysosomal storage diseases in the United States. The company's transport vehicle (TV)-enabled programs include DNL310 ETV, an IDS enzyme replacement therapy program for MPS II; TAK-594/DNL593 which is in Phase 1/II for frontotemporal dementia-granulin; DNL126 program for MPS IIIA; and DNL622 for MPS I, as well as other preclinical programs that target amyloid beta and HER2. Its brain-penetrant small molecule programs comprise BIIB122/DNL151 LRRK2 inhibitor program for Parkinson's disease; SAR443820/DNL788 RIPK1 inhibitor program for CNS disease; DNL343 eIF2B Activator program for amyotrophic lateral sclerosis; and SAR443122/DNL758 RIPK1 inhibitor program for peripheral inflammatory diseases. It also provides early stage program include TAK-594/DNL593 program for FTD-GRN; DNL126 program for MPS IIIA, a Sanfilippo Syndrome A; DNL622 for MPS I which is Hurler syndrome; Antibody Transport Vehicle Amyloid beta program; Oligonucleotide Transport Vehicle platform, a novel class of biotherapeutics to address the root cause of diseases through modulation of gene expression; and other TV-enabled discovery programs. The company has collaboration agreements with Biogen MA Inc. and Biogen International GmbH; Genzyme Corporation; Takeda Pharmaceutical Company Limited; F-star Gamma Limited, F-star Biotechnologische Forschungs-und Entwicklungsges m.b.H, and F-star Biotechnology Limited; and Genentech, Inc. The company was formerly known as SPR Pharma Inc. and changed its name to Denali Therapeutics Inc. in March 2015. Denali Therapeutics Inc. was incorporated in 2013 and is headquartered in South San Francisco, California.",Biotechnology,142540000.0,0.79487,15.56,33.31,15.45,1183063296.0,1.331,-7.49,-21.69,-9.06,-16.79,-37.64,-27.49,1449.0,1483.0,1686.0,1936.0,2328.0,2699.0,2818.0,-104.5,514.8,475.8,727.3,984.8,1195.0,1231.0,-141.7,643.5,605.8,1031.0,1238.0,1398.0,1437.0,-187.6,593.6,555.9,979.7,1185.0,1436.0,1475.0,USD,Million
SPRC,SciSparc Ltd.,3271440.0,Healthcare,"SciSparc Ltd., a clinical-stage pharmaceutical company, develops drugs based on cannabinoid therapies. Its drug development programs include SCI-110 for the treatment of Tourette syndrome and Alzheimer's disease and agitation; SCI-160 for the treatment of pain; SCI-210 for the treatment of autism spectrum disorder and status epilepticus; and CannAmide, an anti-inflammatory and chronic pain solution. The company has an agreement with Procaps to develop and commercially manufacture SCI-110 and CannAmide, a palmitoylethanolamide oral tablet in softgel capsule form. It also has an agreement with The Israeli Medical Center for Alzheimer's to conduct a phase IIa clinical trial to evaluate the safety, tolerability, and efficacy of SCI-110 in patients with Alzheimer's disease and agitation; and a collaboration with Clearmind Medicine Inc. The company was formerly known as Therapix Biosciences Ltd. and changed its name to SciSparc Ltd. in January 2021. SciSparc Ltd. was incorporated in 2004 and is headquartered in Tel Aviv-Yafo, Israel.",Biotechnology,2703670.0,0.02424,1.21,23.66,1.15,102890.0,1.257,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.347,2.879,0.0,0.0,-4.794,-3.482,-5.789,-2.592,-5.122,0.0,0.0,-3.986,-2.387,-5.755,-8.1,-5.282,0.0,0.0,-4.108,-2.551,-5.768,-8.287,-5.773,0.0,0.0,USD,Million
AAME,Atlantic American Corporation,39172380.0,Financial Services,"Atlantic American Corporation, through its subsidiaries, provides life and health, and property and casualty insurance products in the United States. It operates through American Southern and Bankers Fidelity segments. The company offers property and casualty insurance products, including commercial automobile insurance coverage for state governments, local municipalities, and other motor pools and fleets; general liability; and inland marine insurance products. It also provides surety bond coverage for subdivision construction; school bus contracts; and performance and payment bonds. In addition, the company offers individual and group whole life insurance products; Medicare supplement insurance products; and other accident and health insurance products comprising various individual and group policies for the payment of standard benefits for the treatment of diagnosed cancer and other critical illnesses, as well as various other products, such as short-term nursing facility care, accident only, hospital indemnity, and disability coverages. It markets its products through independent agents and brokers. The company was founded in 1937 and is based in Atlanta, Georgia. Atlantic American Corporation is a subsidiary of Atlantic American / Delta Group.",Insurance - Life,20402300.0,0.05582,1.91,3.0,1.49,50276372.0,0.334,-2.55,-31.29,-27.38,4.95,-22.98,-22.04,7580.0,8042.0,9357.0,10711.0,11144.0,11203.0,10957.0,1888.0,1691.0,2568.0,1766.0,1483.0,3365.0,3393.0,4744.0,5156.0,5983.0,6644.0,7087.0,7085.0,7219.0,2688.0,2888.0,3132.0,2352.0,3025.0,4906.0,5131.0,USD,Million
STX,Seagate Technology Holdings plc,18250504192.0,Technology,"Seagate Technology Holdings plc provides data storage technology and solutions in Singapore, the United States, the Netherlands, and internationally. It provides mass capacity storage products, including enterprise nearline hard disk drives (HDDs), enterprise nearline solid state drives (SSDs), enterprise nearline systems, video and image HDDs, and network-attached storage drives. The company also offers legacy applications comprising Mission Critical HDDs and SSDs; external storage solutions under the Seagate Ultra Touch, One Touch, and Expansion product lines, as well as under the LaCie brand name; desktop drives; notebook drives, DVR HDDs, and gaming SSDs. In addition, it provides Lyve edge-to-cloud mass capacity platform. The company sells its products primarily to OEMs, distributors, and retailers. Seagate Technology Holdings plc was founded in 1978 and is based in Dublin, Ireland.",Computer Hardware,209511008.0,0.93375,87.11,101.26,54.47,23169099776.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,55409.0,50366.0,49552.0,51727.0,66058.0,64796.0,63683.0,5969.0,3898.0,12607.0,14822.0,22432.0,24995.0,20948.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,22614.0,18907.0,14932.0,18397.0,33988.0,32850.0,30725.0,USD,Million
MNOV,"MediciNova, Inc.",66702856.0,Healthcare,"MediciNova, Inc., a biopharmaceutical company, focuses on developing novel and small molecule therapeutics for the treatment of serious diseases with unmet medical needs in the United States. It is developing MN-166 (ibudilast), an oral anti-inflammatory and neuroprotective agent for treating neurological and other disorders, such as primary and secondary progressive multiple sclerosis, amyotrophic lateral sclerosis, chemotherapy-induced peripheral neuropathy, degenerative cervical myelopathy, glioblastoma, and substance dependence and addiction, as well as prevention of acute respiratory distress syndrome, and long COVID. The company's product pipeline also includes MN-221 (bedoradrine), a selective beta-2-adrenergic receptor agonist for the treatment of acute exacerbations of asthma; MN-001 (tipelukast), an orally bioavailable small molecule compound to treat fibrotic and other diseases, including nonalcoholic fatty liver disease and idiopathic pulmonary fibrosis; and MN-029 (denibulin), a tubulin binding agent for treating solid tumor cancers. It has license agreements with Kyorin Pharmaceutical Co., Ltd; Angiogene Pharmaceuticals, Ltd.; and Meiji Seika Kaisha, Ltd. The company was incorporated in 2000 and is headquartered in La Jolla, California.",Biotechnology,49046200.0,0.21136,1.355,2.66,1.26,16084807.0,0.687,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.038,0.0,1.0,0.0,0.0,-12.94,-13.85,-10.13,-14.07,-8.572,-11.3,-11.7,0.0,-14.16,0.0,0.0,0.0,0.0,0.0,-14.03,-14.18,-10.22,-14.63,-9.9,-11.3,-11.7,USD,Million
WPRT,Westport Fuel Systems Inc.,100814928.0,Consumer Cyclical,"Westport Fuel Systems Inc. engages in the engineering, manufacturing, and supplying alternative fuel systems and components for use in transportation applications in Europe, Asia, North America, South America, and internationally. The company operates through two segments, Original Equipment Manufacturers and Independent Aftermarket. It offers alternative fuel systems and components, such as liquefied petroleum gas (LPG), compressed natural gas (CNG), liquefied natural gas (LNG), renewable natural gas or biomethane, and hydrogen; and pressure regulators, injectors, electronic control units, valves and filters, complete bi-fuel, mono-fuel and dual-fuel LPG and natural gas conversion kits and high-pressure hydrogen components. The company provides Westport's LNG high pressure direct injection 2.0 fuel system and bi-fuel products; offers turnkey solutions covering all process phases, including prototyping, development, calibration, validation, homologation, vehicle conversion and logistic services, as well as systems for diesel-powered vehicles; and supplies hydrogen fuel system components for light, medium, and heavy-duty applications. It offers its products under the AFS, BRC, Emer, GFI, HPDI, Stako, Prins, Zavoli, OMVL, TA Gas Technology, Vialle, and Valtek brands. The company was formerly known as Westport Innovations Inc. and changed its name to Westport Fuel Systems Inc. in June 2016. Westport Fuel Systems Inc. was incorporated in 1995 and is headquartered in Vancouver, Canada.",Auto Parts,17223200.0,0.12895,5.62,12.0,4.9,124872128.0,2.968,-1.66,-22.38,0.0,8.29,-28.85,-15.11,20109.0,20862.0,21310.0,23256.0,25284.0,28098.0,30173.0,1476.0,1299.0,1758.0,1591.0,1857.0,1938.0,2146.0,2777.0,2807.0,2925.0,3246.0,3469.0,3728.0,4057.0,2117.0,2132.0,2205.0,2479.0,2682.0,3027.0,3329.0,GBP,Million
LSCC,Lattice Semiconductor Corporation,9845113856.0,Technology,"Lattice Semiconductor Corporation, together with its subsidiaries, develops and sells semiconductor products in Asia, Europe, and the Americas. The company offers field programmable gate arrays that consist of four product families, including the Lattice Certus and ECP, Mach, iCE, and CrossLink. It also provides video connectivity application specific standard products. In addition, the company licenses its technology portfolio through standard IP and IP core licensing, patent monetization, and IP services. It sells its products directly to customers, and indirectly through a network of independent manufacturers' representatives and independent distributors. The company primarily serves original equipment manufacturers in the communications and computing, consumer, and industrial, and automotive markets. Lattice Semiconductor Corporation was incorporated in 1983 and is headquartered in Hillsboro, Oregon.",Semiconductors,137540000.0,1.1024,71.58,98.3,51.96,9733862400.0,1.379,1.94,-8.92,3.98,0.21,-20.88,3.75,125843.0,143015.0,168088.0,198270.0,211915.0,244329.0,279241.0,39240.0,44281.0,61271.0,72738.0,72361.0,86781.0,99162.0,54641.0,65755.0,81602.0,97843.0,103555.0,125596.0,145313.0,42959.0,52959.0,69916.0,83383.0,89694.0,106819.0,122154.0,USD,Million
ACIU,AC Immune SA,234390368.0,Healthcare,"AC Immune SA, a clinical stage biopharmaceutical company, discovers, designs, and develops medicines and diagnostic products for the prevention and treatment of neurodegenerative diseases associated with protein misfolding. The company's SupraAntigen and Morphomer platforms are designed to generate biologics and small molecules, which selectively interact with misfolded proteins that are common in a range of neurodegenerative diseases. It is developing Crenezumab, a humanized, conformation-specific monoclonal antibody used to slow Alzheimer's disease (AD) progression; and Semorinemab, an investigational monoclonal anti-Tau antibody that targets the N-terminal portion of the Tau protein and is designed to bind to Tau and slow its spread between neurons for the treatment of AD. The company is also developing ACI-24.060 for the treatment of down syndrome-related AD; ACI-7104.056, to treat Parkinson's disease; and ACI-35.030, designs to stimulate a patient's immune system to produce antibodies against pathological phosphorylated Tau. In addition, it is developing diagnostic programs, consisting of PI-2620, a Tau diagnostic for AD, as well as non-AD Tauopathies; and ACI-12589, a-sync PET tracer that supports the differential diagnosis of multiple system atrophy from other neurodegenerative disease. Further, the company is researching and developing Morphomer Tau aggregation inhibitors to evaluate candidates in AD and NeuroOrphan Tauopathies. Additionally, it has discovery and preclinical stage molecules targeting range of neurodegenerative diseases, which include diagnostics targeting TDP-43, alpha-synuclein, and NLRP3. The company has license agreements and collaborations with Genentech, Inc.; Janssen Pharmaceuticals, Inc.; Life Molecular Imaging SA; and Eli Lilly and Company. AC Immune SA was incorporated in 2003 and is headquartered in Lausanne, Switzerland.",Biotechnology,98898896.0,0.30229,2.37,5.14,1.78,123119672.0,1.013,0.0,0.0,0.0,0.0,0.0,0.0,111.0,15.43,0.0,3.935,14.8,8.325,61.1,45.44,-61.92,-73.0,-70.75,-54.23,-66.6,-23.83,45.81,-59.29,-76.6,-68.49,-51.41,-72.5,-50.5,44.54,-61.26,-79.01,-70.85,-53.62,-67.84,-5.359,CHF,Million
ASTL,Algoma Steel Group Inc.,821600704.0,Basic Materials,"Algoma Steel Group Inc. produces and sells steel products primarily in North America. The company provides flat/sheet steel products, including temper rolling, cold rolled, hot-rolled pickled and oiled products, floor plate, and cut-to-length products for the automotive industry, hollow structural product manufacturers, and the light manufacturing and transportation industries; and plate steel products that consist of rolled, hot-rolled, and heat-treated for use in the construction or manufacture of railcars, buildings, bridges, off-highway equipment, storage tanks, ships, and military applications. Algoma Steel Group Inc. was founded in 1901 and is headquartered in Sault Ste. Marie, Canada.",Steel,104038000.0,0.69997,7.71,10.25,6.345,863436800.0,1.524,0.0,0.0,0.0,0.0,0.0,0.0,43165.0,44611.0,63495.0,55554.0,54041.0,53021.0,52722.0,8010.0,9769.0,21094.0,12420.0,10058.0,12209.0,11907.0,21197.0,23902.0,37720.0,26272.0,23892.0,24936.0,24897.0,16813.0,19623.0,33023.0,20508.0,15498.0,18382.0,17579.0,USD,Million
HUDAR,Hudson Acquisition I Corp.,0.0,0,"Hudson Acquisition I Corp. does not have significant operations. It focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company was incorporated in 2021 and is based in New York, New York.",0,0.0,0.0,0.2195,2.5,0.1,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6791215.0,6644359.0,5766718.0,8749752.0,11811300.0,11471700.0,11439074.0,203004.0,218185.0,179262.0,210774.0,280900.0,224600.0,309596.0,659808.0,674315.0,626873.0,751491.0,995300.0,1054900.0,1075301.0,411596.0,424266.0,366329.0,387653.0,506500.0,534200.0,549740.0,JPY,Million
NEXI,"NexImmune, Inc.",4716405.0,Healthcare,"NexImmune, Inc., a clinical-stage biotechnology company, engages in developing therapies with curative potential for patients with cancer and other life-threatening immune-mediated diseases. It develops approaches to T cell immunotherapies based on its proprietary Artificial Immune Modulation, a nanoparticle technology platform. The company's product candidates include NEXI-001, an allogeneic cell therapy, which is in Phase I/II clinical trials for the treatment of patients with acute myeloid leukemia; NEXI-002, an autologous cell therapy that is in Phase I/II clinical trials for the treatment of patients with relapsed and/or refractory in multiple myeloma; and NEXI-003, a candidate targeted against HPV-associated malignancies, which is in preclinical stage. The company was incorporated in 2011 and is headquartered in Gaithersburg, Maryland.",Biotechnology,1371050.0,0.08835,3.26,28.695,1.25,1335983.0,1.876,3.49,-43.3,-37.07,-19.9,-66.35,46.85,0.0,0.0,0.0,0.0,0.0,0.0,0.0,-20.55,-29.87,-50.9,-62.51,-32.34,0.0,0.0,-20.45,-27.23,-52.39,-62.09,-28.16,0.0,0.0,-20.89,-27.85,-53.26,-63.08,-29.18,0.0,0.0,USD,Million
NRDS,"NerdWallet, Inc.",1075600000.0,Communication Services,"NerdWallet, Inc. operates a digital platform that provides consumer-driven advice about personal finance by connecting individuals and small and mid-sized businesses with financial products providers in the United States, the United Kingdom, Australia, and Canada. Its platform offers guidance to consumers through educational content, tools and calculators, and product marketplaces, as well as through NerdWallet app for various financial products, including credit cards, mortgages, insurance, SMB products, personal loans, banking, investing, and student loans. The company was founded in 2009 and is based in San Francisco, California.",Internet Content & Information,46031100.0,0.65279,13.76,17.3,6.38,966720384.0,1.39,0.0,0.0,0.0,0.0,0.0,0.0,0.0,379.6,538.9,599.4,621.7,696.9,0.0,5.3,-42.5,-10.2,-11.8,23.55,42.17,0.0,0.0,27.1,67.1,97.6,113.0,145.9,0.0,0.0,-39.0,-19.0,3.6,24.91,48.55,0.0,USD,Million
CDNA,"CareDx, Inc",426137600.0,Healthcare,"CareDx, Inc. engages in the discovery, development, and commercialization of diagnostic solutions for transplant patients and caregivers in the United States and internationally. It also provides AlloSure Kidney, a donor-derived cell-free DNA (dd-cfDNA) solution for kidney transplant patients; AlloMap Heart, a gene expression solution for heart transplant patients; AlloSure Heart, a dd-cfDNA solution for heart transplant patients; and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. The company offers Olerup SSP, which is used to type human leukocyte antigen (HLA) alleles based on sequence specific primer technology; QTYPE that enables precision in HLA typing; and Ottr, a transplant patient management software. In addition, it provides AlloSeq Tx, a high-resolution HLA typing solution; AlloSeq cfDNA, a surveillance solution to measure dd-cfDNA in blood; AlloSeq HCT, a solution for chimerism testing for stem cell transplant recipients; Allocell, a surveillance solution that monitors the level of engraftment and persistence of allogeneic cells for patients who have received cell therapy transplants; and XynQAPI cloud-based transplant quality management software, as well as AlloCare, a mobile app that offers a patient-centric resource for transplant recipients. The company offers its products directly to customers, as well as through third-party distributors and sub-distributors. It has a license agreement with Illumina, Inc. for the distribution, development, and commercialization of NGS products and technologies; and Cibiltech SAS to commercialize iBox, a software for the predictive analysis of post-transplantation kidney allograft loss. The company was formerly known as XDx, Inc. and changed its name to CareDx, Inc. in March 2014. The company was incorporated in 1998 and is headquartered in South San Francisco, California.",Diagnostics & Research,51778500.0,0.97484,7.98,12.93,4.8,211995616.0,1.446,-3.62,-17.9,-19.56,53.17,-5.45,-33.5,127.1,192.2,296.4,321.8,280.3,267.0,286.6,-21.97,-18.71,-30.66,-76.61,-190.3,-80.4,-64.05,4.164,7.962,17.83,-17.54,-37.98,-27.18,-5.823,-24.53,-22.53,-29.73,-77.23,-203.4,-92.68,-74.97,USD,Million
FTAIN,FTAI Aviation Ltd.,0.0,Industrials,"FTAI Aviation Ltd. owns and acquires aviation and offshore energy equipment for the transportation of goods and people worldwide. It operates through two segments, Aviation Leasing and Aerospace Products. The Aviation Leasing segment owns and manages aviation assets, including aircraft and aircraft engines, which it leases and sells to customers. As of December 31, 2023, this segment owned and managed 363 aviation assets consisting of 96 commercial aircraft and 267 engines, including eight aircraft and seventeen engines that were located in Russia. The Aerospace Products segment develops, manufactures, repairs, and sells aircraft engines and aftermarket components for aircraft engines. The company was founded in 2011 and is headquartered in New York, New York.",Rental & Leasing Services,0.0,0.21076,24.8201,26.09,21.75,4915393536.0,1.971,0.0,0.0,0.0,0.0,0.0,0.0,7341.0,5489.0,7246.0,6929.0,4801.0,6074.0,7466.0,712.7,302.8,605.4,716.2,693.4,894.2,1130.0,908.0,417.9,678.6,746.8,523.6,680.3,900.6,765.5,261.0,527.0,572.3,349.2,516.0,697.2,in,Million
RIVN,"Rivian Automotive, Inc.",8836146176.0,Consumer Cyclical,"Rivian Automotive, Inc., together with its subsidiaries, designs, develops, manufactures, and sells electric vehicles and accessories. The company offers consumer vehicles, including a two-row, five-passenger pickup truck under the R1T brand, a three-row, seven-passenger sport utility vehicle under the R1S name. It provides consumer services, such as digital financing and leasing, telematics-based insurance, vehicle maintenance and repair services, software services, and charging solutions. In addition, the company designs, develops, manufactures, and operates the Rivian Adventure Network Direct Current fast chargers, and offers access to Combined Charging Standard, as well as FleetOS, a proprietary, end-to-end centralized fleet management subscription platform. Further, it offers Rivian Commercial Van platform for Electric Delivery Van with collaboration with Amazon.com, Inc. The company sells its products directly to customers in the consumer and commercial markets. Rivian Automotive, Inc. was founded in 2009 and is based in Irvine, California.",Auto Manufacturers,969625024.0,0.51569,8.84,28.06,8.26,4191654656.0,1.886,0.0,0.0,0.0,0.0,0.0,0.0,10150.0,11604.0,13328.0,14410.0,15812.0,16950.0,17944.0,1391.0,1752.0,2165.0,2173.0,2347.0,2467.0,2623.0,2192.0,2734.0,3245.0,3312.0,3595.0,3869.0,4110.0,1921.0,2419.0,2917.0,2954.0,3186.0,3400.0,3618.0,USD,Million
HUMAW,"Humacyte, Inc.",0.0,Healthcare,"Humacyte, Inc. engages in the development and manufacture of off-the-shelf, implantable, and bioengineered human tissues for the treatment of diseases and conditions across a range of anatomic locations in multiple therapeutic areas. The company using its proprietary and scientific technology platform to engineer and manufacture human acellular vessels (HAVs) to be implanted into patient without inducing a foreign body response or leading to immune rejection. It is developing a portfolio of HAVs, which would target the vascular repair, reconstruction, and replacement market, including vascular trauma; arteriovenous access for hemodialysis; peripheral arterial disease; pediatric heart surgery; and coronary artery bypass grafting, as well as for the delivery of cellular therapy, including pancreatic islet cell transplantation to treat Type 1 diabetes. The company was founded in 2004 and is headquartered in Durham, North Carolina.",Biotechnology,0.0,0.0,0.6499,0.6499,0.64,0.0,1.452,0.0,0.0,0.0,0.0,0.0,0.0,1.263,1.565,0.0,2.85,30.14,0.0,0.0,-26.48,-11.96,-110.8,-102.9,-88.88,0.0,0.0,-75.03,-82.55,-85.5,-81.6,-59.3,0.0,0.0,-81.21,-84.58,-100.0,-104.6,-88.1,0.0,0.0,USD,Million
